Susan Benton, Director at Ocuphire Pharma, Inc. (OCUP), bought 20,000 shares at $4.57 ($91K) on 2021-09-02, disclosed to the SEC on 2021-09-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.